Uncovering repurposed medicines to fight liver fibrosis

Accelerating discovery of liver disease mechanisms

Filippo Menolascina uses Co-Scientist to identify new liver disease treatments and explain why existing drugs only help certain patients.

Uniting biological toolkits for a new approach to ALS

Co-Scientist unites Boston Children’s Hospital and MIT’s labs to explore new RNA-based treatments for ALS.

Finding the molecular switches behind new infectious diseases

Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.

Fast-tracking genetic leads to reverse cellular aging

Biologists use Co-Scientist to find novel factors that successfully rejuvenate human cells.

A Precedent-Guided Co-Scientist for Side-Effect-Aware Drug Redesign

arXiv:2607. 02944v1 Announce Type: cross Abstract: We propose PRECEDE, a precedent-guided co-scientist for side-effect-aware drug redesign that revises a parent compound to mitigate a specified side effect while preserving therapeutic function.

Accelerating the development of life-saving treatments

Accelerating the development of life-saving treatments.

Decoding genetics with OpenAI o1

Geneticist Catherine Brownstein demonstrates how OpenAI o1 can speed up the process of diagnosing rare medical challenges.

Accelerating life sciences research

Discover how a specialized AI model, GPT-4b micro, helped OpenAI and Retro Bio engineer more effective proteins for stem cell therapy and longevity research.

Inside Genebench-Pro

Opening new paths in aging research

Calico Life Sciences uses Co-Scientist to connect scattered findings and generate new leads in aging research.

A near-autonomous AI chemist improves a challenging reaction in medicinal chemistry

OpenAI and Molecule. one show how a near-autonomous AI chemist using GPT-5.

Introducing GPT-Rosalind for life sciences research

OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.